Yves Boucher

Active 1990–2025

86
Papers
25,437
Citations
71
h-index
82
i10-index

Citations

Citations per year for Yves Boucher1990: 2 citations1991: 7 citations1992: 7 citations1993: 10 citations1994: 19 citations1995: 20 citations1996: 33 citations1997: 61 citations1998: 41 citations1999: 69 citations2000: 58 citations2001: 113 citations2002: 143 citations2003: 159 citations2004: 195 citations2005: 236 citations2006: 291 citations2007: 289 citations2008: 251 citations2009: 218 citations2010: 255 citations2011: 334 citations2012: 310 citations2013: 303 citations2014: 285 citations2015: 326 citations2016: 309 citations2017: 334 citations2018: 322 citations2019: 789 citations2020: 961 citations2021: 879 citations2022: 699 citations2023: 524 citations2024: 693 citations2025: 369 citations2026: 18 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,834 citing papers, 31.4% of this breakdownChina: 1,149 citing papers, 12.7% of this breakdownUnited Kingdom: 525 citing papers, 5.8% of this breakdownGermany: 462 citing papers, 5.1% of this breakdownItaly: 321 citing papers, 3.6% of this breakdownFrance: 317 citing papers, 3.5% of this breakdownCanada: 297 citing papers, 3.3% of this breakdownJapan: 257 citing papers, 2.8% of this breakdownAustralia: 221 citing papers, 2.5% of this breakdownNetherlands: 209 citing papers, 2.3% of this breakdownSwitzerland: 181 citing papers, 2% of this breakdownSouth Korea: 162 citing papers, 1.8% of this breakdown
0%31.4%Other 23.2%

Fields

  • Medicine39%
  • Biochemistry, Genetics and Molecular Biology35.2%
  • Engineering7.6%
  • Materials Science7.2%
  • Immunology and Microbiology3.9%
  • Dentistry2%
  • Other5.1%

Topics

  • Angiogenesis and VEGF in Cancer6.1%
  • Cancer Cells and Metastasis4.7%
  • Cancer, Hypoxia, and Metabolism4.6%
  • Nanoplatforms for cancer theranostics3.6%
  • Nanoparticle-Based Drug Delivery3.4%
  • Cellular Mechanics and Interactions3.1%
  • Other74.5%

Coauthors

All papers

Open in search
  1. Normalization of the Vasculature for Treatment of Cancer and Other Diseases

    Authors: , , , , , , - Physiological Reviews 2011 cited by 1,574

  2. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 917

  3. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 715

  4. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore S. Hong - JAMA Oncology 2019 cited by 510

  5. Solid stress and elastic energy as measures of tumour mechanopathology

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2016 cited by 444

  6. Mechanical compression drives cancer cells toward invasive phenotype

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 630

  7. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 cited by 465

  8. Stromal response to Hedgehog signaling restrains pancreatic cancer progression

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 502

  9. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 1,957

  10. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

    Authors: , , , , , - Cancer Research 2004 cited by 1,186

  11. Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies

    Authors: , , , - Annual Review of Chemical and Biomolecular Engineering 2011 cited by 589

  12. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 202

  13. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2016 cited by 252

  14. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 325

  15. Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 256

  16. Solid stress generated by spheroid growth estimated using a linear poroelasticity model☆

    Authors: , , , , - Microvascular Research 2003 cited by 299

  17. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 219

  18. Compression of Pancreatic Tumor Blood Vessels by Hyaluronan Is Caused by Solid Stress and Not Interstitial Fluid Pressure

    Authors: , , , , , , , , , , - Cancer Cell 2014 cited by 198

  19. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

    Authors: , , , , , , - Nature Medicine 2003 cited by 836

  20. Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 598

  21. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

    Authors: , , , , , , , , , , , - Science 2002 cited by 969

  22. Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 51

  23. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

    Authors: , , - 1990 cited by 765

  24. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.

    Authors: , - 1992 cited by 514